ConductScience.org, home

Paper3668258

Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).

Karpinski KF and 2 others. J Immunol Methods, 1987. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). Papers, record 3668258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3668258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).
PubMed
Journal
J Immunol Methods
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
3.08
iCite
Revised in PubMed
2019-07-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karpinski KFK F
2Hayward SS
3Tryphonas HH

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Enzyme-Linked Immunosorbent AssayMajor topic
Immunoglobulin GMajor topic
Immunoglobulin MMajor topic
Statistics as TopicMajor topic
Animals
Dose-Response Relationship, Immunologic
Humans
Macaca mulatta
Spectrophotometry

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
39548371A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection.BMC Infect Dis2024https://conductscience.org/library/papers/39548371PubMed
39085631Rapid prototyping of thermoplastic microfluidic devices via SLA 3D printing.Sci Rep2024https://conductscience.org/library/papers/39085631PubMed
38312015Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico.Epidemiol Infect2024https://conductscience.org/library/papers/38312015PubMed
37733444Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan.JCI Insight2023https://conductscience.org/library/papers/37733444PubMed
35336970A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs.Viruses2022https://conductscience.org/library/papers/35336970PubMed
32048889
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.
Hum Vaccin Immunother2020https://conductscience.org/library/papers/32048889PubMed
29883460Absorbance summation: A novel approach for analyzing high-throughput ELISA data in the absence of a standard.PLoS One2018https://conductscience.org/library/papers/29883460PubMed
29630439
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
Hum Vaccin Immunother2018https://conductscience.org/library/papers/29630439PubMed
25278086
A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia.
BMC Infect Dis2014https://conductscience.org/library/papers/25278086PubMed
24004825Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.Hum Vaccin Immunother2014https://conductscience.org/library/papers/24004825PubMed
23434737Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: a double-blind randomized trial.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23434737PubMed
22327497
Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: a randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy.
Hum Vaccin Immunother2012https://conductscience.org/library/papers/22327497PubMed
18283506Kinetics of growth and leukotoxin production by Mannheimia haemolytica in continuous culture.J Ind Microbiol Biotechnol2008https://conductscience.org/library/papers/18283506PubMed
12414755Use of coefficient of variation in assessing variability of quantitative assays.Clin Diagn Lab Immunol2002https://conductscience.org/library/papers/12414755PubMed
8335014Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children.Eur J Pediatr1993https://conductscience.org/library/papers/8335014PubMed
7767946Preclinical pharmacology of cholera toxin.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7767946PubMed
2787696Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2787696PubMed
2651245The number of plaque-forming cells and its "normal range".Folia Microbiol (Praha)1989https://conductscience.org/library/papers/2651245PubMed
1909345Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay.J Clin Microbiol1991https://conductscience.org/library/papers/1909345PubMed
1892756Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.Br J Cancer1991https://conductscience.org/library/papers/1892756PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3668258

GET https://conductscience.org/api/papers/v1/3668258/cited_by?page=2